eph, the largest known family of putative growth factor receptors. by Tuzi, N. L. & Gullick, W. J.
Br. J. Cancer (1994), 69, 417-421
© Macmillan Press Ltd., 1994
REVIEW
eph, the largest known family ofputative growth factor receptors
N.L. Tuzi & W.J. Gullick
Molecular Oncology Laboratory, ICRF Oncology Unit, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane
Road, London W12 ONN, UK.
Receptor tyrosine kinases (RTKs) and their ligands are
involved in many different processes including cellular
differentiation, proliferation, embryonic development and
some cases of neoplastic growth (Ullrich & Schlessinger,
1990; Pawson & Bernstein, 1990). The RTKs all have a
similar structure consisting of an extracellular ligand-binding
domain, a hydrophobic transmembrane region and an int-
racellular domain that contains the tyrosine kinase catalytic
activity (Yarden & Ullrich, 1988). Receptors of this type may
be categorised according to their overall layout, their regions
of sequence homology and on the similarity of their ligands.
Several subclasses or families of RTKs can be defined using
this approach. One such subclass is the recently discovered
family of RTKs termed eph, which currently consists of seven
distinct members, eph, eck, elk, cek5, mek4/cek4/hek, sek and
hek2, all of whose cDNAs have been fully sequenced. The
relationships between the Eph family members is illustrated
in a phylogenetic tree (Figure 1) constructed using the amino
acid sequence from the consensus sequence Gly-X'Gly-X-X-
Gly, found towards the amino terminus of the catalytic
region (Hanks et al., 1988), to the carboxy-terminal tail. The
tree was constructed using the De Soete Tree Fit program
(De Soete, 1983, 1984). There are at least another five eph-
related putative receptors reported in the literature that have
not yet been fully sequenced. Taken together, this appears to
be the largest known family of RTKs. The pattern of expres-
sion of mRNA or protein of the full and partial length
eph-like receptors is summarised in Table I.
eph family characteristics
The shared characteristics of the Eph family which allow it to
be considered as a subclass of RTKs are depicted in Figure
2. The extracellular domain contains an immunoglobulin-like
(Ig) loop (although this homology is very weak) and two
fibronectin type III repeats. Ig loops are found in several
RTK extracellular domains, notably in the fibroblast growth
factor (FGF) receptor and platelet-derived growth factor
receptor families. Fibronectin type III repeats are found in
many proteins, including some RTKs and a number of
neural cell adhesion molecules. The function of these motifs
in growth factor receptors is unclear, however they may be
involved in cell-cell interactions. There is also one cysteine-
rich region, containing 13 cysteine residues, in the extracel-
lular domain. The spacing of the cysteines is different to the
cysteine-rich region found in the type I RTK family, which
includes the epidermal growth factor (EGF) receptor, c-erbB-
2, c-erbB-3 (Prigent & Lemoine, 1992) and c-erbB-4 receptors
(Plowman et al., 1993), and the type II family, which consists
ofthe insulin receptor, IGF-I and the insulin receptor-related
receptor.
So far no ligands for any of the Eph RTK family have
been reported, and therefore they should be considered
'putative' growth factor receptors. Lack of known ligands
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severely restricts the studies that can be performed on their
functions. However, several reports on the expression pattern
of the mRNA and protein of the various members have been
performed, and this may ultimately aid in the discovery of
the ligands for this family and help unravel their normal
cellular functions.
eph
eph, the first receptor to be discovered, was isolated from a
human hepatocellular carcinoma cell line cDNA library
(Hirai et al., 1987). The eph gene has been well conserved
throughout evolution as the human eph cDNA probe
detected specific bands on a Southern blot of DNA from
mouse, chicken, rat and Drosophila melanogaster. The human
eph gene has been mapped to chromosome 7 and codes for a
3.5 kb mRNA. eph has been found to be most highly ex-
pressed at the mRNA level in adult rat liver, lung and kidney
and to a lesser extent in the testis (Table I). It was also noted
that some human breast, lung, liver and colon carcinomas
overexpress eph mRNA compared with normal tissues, but
no gene amplification was seen (Maru et al., 1988). This
observation of overexpression without gene amplification has
been reported for several RTKs, e.g. c-erbB-3 in breast car-
cinomas (Lemoine et al., 1992). When the human breast
cancer cell line MCF-7 was analysed for the expression of
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Figure 1 Phylogenetic tree of the Eph family ofreceptor tyrosine
kinases. The tree was constructed using the De Soete Tree Fit
program. The amino acid sequence from the consensus sequence
GXGXXG, of the catalytic region, to the carboxy-terminal tail
was used. The predicted amino acid sequences of human Eph,
Hek, Hek2, Erk and Eck, rat Eek and Elk, chicken Cek4, Cek5,
Cek6, Cek7, Cek8, Cek9 and CeklO and mouse Mek4 and Sek
were used in the construction for the above tree. The following
partially sequenced Eph-like receptors were of insufficient length
to be included; rat Tyro 1, Tyro 4, Tyro 5, Tyro 6 and Tyro 11
and human Tk2.
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Table I Summary of the expression of mRNA or protein of all fully and partially sequenced eph-like receptors
mRNA Overexpression ofmRNA in
Name Species Homologue(s) (kb) Normaldistribution ofmRNA orprotein human cancers
eph Human NI 3.5 Highest inadultratliver, lungandkidney. Lower Somelung,liver, breastand
elk Rat cek6a 4.0
eck Human NI 4.7
cekS Chicken erka/tyro5a 4.4and 10
sek Mouse cek8altyrola 7.0
cek4 Chicken mek4/hekltyro4a 7.5
mek4 Mouse cek4lhekltyro4a 6.0and 3.4
hek Human cek4lmek4/tyro4a 5.5-6.0
hek2 Human ceklOa/tyro6a 4.6
eeka Rat NI ND
erk* Human cek5ltyro5a 4.0
in testes
Highest inadultratbrain andembryonicday
14-16 stomach. Lowerinadult rattestes
Highest inratlung, skin, smallintestine andovary.
Lowerinkidney, brain, spleen and submaxillary
gland
Highestinchicken embryonic day 10 and adult
brain. Lowerin kidney, lung,thigh andintestine
Highestinadultmouse brain. Lowerinheart, lung
and kidney. Expressed duringembryonicbrain
development
Highest inadultchicken brain and retina, but
detectable inalladulttissue, exceptliver
Highestinadultmousebrain. Lowerin testes
(3.4 kb)
Undetectable attheproteinlevel
Highestinhumanpancreas, lung, placenta, brain
andkidney. Lowerinheart, skeletal muscle and
liver
Ratbrain
Highest inadultratlung. Lowerinplacenta, brain
andkidney. Expressed in 16day ratembryo
stomach
colon carcinomas
2/3 gastriccarcinomas
1/28 CLLand2/39 AML
3/3 gastriccarcinomas
tyrola Rat sek/cek8a
tyro4a Rat cek4/mek4/hek
tyroSa Rat cek5/erka
tyro6a Rat
tyrolla Rat
hek2/ceklIa
NI
cek6a Chicken elk
ND Constantexpression from ratembryonicday 12
to adulthood inCNS
ND Constantexpressionfrom ratembryonicday 12
to birth in CNS
ND Constantexpressionfrom ratembryonic day 12
to birth in neural tissue
ND
ND
Maximal in ratembryonic day 12 brain
Highestin ratheartandkidney, lowerinneural
tissue
4.4and 6.5 Highest inchickenembryonicday 10and adult
brain, lung, heartandskeletal muscle.
Lowlevel of6.5 kbinadultbrain
cek7a Chicken NI
cek8a Chicken sek/tyrola
cek9' Chicken NI
4.4,7.0
and 8.5
6.0
Chickenembryonicday 10 brain. Lowlevel of
8.5 kbtranscript inadultbrain
Highestinadultchicken brainand retina. Lowerin
adultkidney, lung, skeletal muscleand thymus
4.4 Highest inchicken adultthymus. Lowerin brain,
retina, kidney, lungandheart. Expressed in
embryonicday 10 brain
ceklOa Chicken hek2/tyro6a 4.4and 6.0 Highest inadultchicken kidney. Lowerin adult
lung. Expressedinembryonic day 10 brain and
bodytissues
aPartially sequenced. NI, noneidentified. ND, notdetermined.
tyrosine kinase mRNAs using the polymerase chain reaction
(PCR), 17/76 tyrosine kinase clones isolated and sequenced
coded for eph (Lehtola et al., 1992). It has also been observed
that when the eph gene is artificially overexpressed in the
mouse fibroblast cell line, NIH 3T3, it allows the transfected
cells to grow in an anchorage-independent manner (deter-
mined by their ability to grow in soft agar) and to form
tumours in nude mice (Maru et al., 1990). Taken together
these data suggest that overexpression of the eph gene may
have a role to play in certain human carcinomas. However
only 50 tumours of different tissue types were examined and
no clinical data were presented to allow the comparison of
tumour characteristics with overexpression to be made.
Larger studies must therefore be performed to allow the
prevalence of overexpression of eph mRNA in human car-
cinomas to be more accurately determined.
elk
The second member of this family to be identified was
termed elk for eph-like kinase and was isolated from a rat
brain cDNA library (Letwin et al., 1988; Lhotak et al.,
1991). This gene appears to have a different pattern of ex-
pression from eph. elk mRNA is 4.0 kb in size and can only
be detected in adult rat brain and to a lesser degree in the
testis. A partial elk cDNA clone was isolated by Iwase et al.
(1993) and used to screen a Northern blot of mRNA isolated
from the stomach of adult, newborn and embryonic rats. It
was found that elk expression increased in the stomach
between embryonic days 14 and 16 but was very low by
embryonic day 18 and in newborn rats. No expression was
seen in the stomach of adults. RNA was also prepared from
three cases ofhuman gastric cancer and it was found that elkTHE eph FAMILY OF GROWTH FACTOR RECEPTORS 419
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Figure 2 Schematic representation of the eph subclass of
putative receptor tyrosine kinases.
mRNA levels were several times higher in 2/3 cases when
compared with RNA prepared from normal gastric tissue
(Table I). elk may therefore have a role to play in human
gastric cancer; however, a larger study must be undertaken
before any firm conclusions may be drawn.
eck
The third member, isolated from a human keratinocyte
cDNA library, has been termed eck (epithelial cell kinase),
and as the name suggests is expressed primarily in cells of
epithelial origin (Lindberg & Hunter, 1990). The mRNA is
4.7 kb in size and was shown to be most highly expressed in
rat lung, skin, small intestine and ovary, with lower levels
seen in the kidney, brain, spleen and submaxillary gland
(Table I). Eck was the first member of this family to be
shown to have intrinsic tyrosine kinase activity. This was
demonstrated by immunoprecipitating the 130 kDa Eck pro-
tein from A431 cells (a human vulva carcinoma-derived cell
line) using an antibody raised against a TrpE fusion protein
containing 101 amino acids from the C-terminal tail of Eck
and then performing an in vitro kinase reaction on the
immune complex. The phosphorylated protein was subjected
to phosphoamino acid analysis, which confirmed that the
majority of the phosphate was on tyrosine.
cek5
cekS (chicken embryo kinase) was isolated from a 10 day
chicken embryo cDNA expression library probed with anti-
phosphotyrosine antibodies (Pasquale, 1991). Antibodies to
the Cek5 protein were raised against a P-gal fusion protein
consisting of 759 amino acid residues (including all of the
intracellular domain) and a synthetic peptide consisting of
the ten amino acids from the C-terminal tail. Using these
antibodies the CekS protein was found to have an apparent
molecular mass of 120 kDa and its pattern of expression in
the 10 day chicken embryo, determined by Western blotting,
was found to be highest in the brain, marginally lower in the
kidney, lung, thigh, gizzard and intestine, and lower still in
the liver, heart and lens (Table I). In the adult chicken
protein expression was found to be most abundant in the
brain and detectable in most of the tissues seen in the em-
bryo, but at a lower level. A more detailed study on the
embryonic and newly hatched chicken brain revealed that
expression decreases gradually during embryonic develop-
ment and after hatching. Immunocytochemical staining
showed that the Cek5 protein is expressed in regions that are
rich in nerve cell processes especially in the hippocampus and
the cerebellum (Pasquale et al., 1992). CekS is specifically
expressed in neurons and may play a role in neuronal
maintenance in the chicken brain.
A variant of cek5 was isolated from the same 10 day
chicken embryo cDNA library and is termed cek5+ (Sajjadi & Pasquale, 1993). This partial length cDNA variant codes
for an eph-like receptor with an insert of 16 amino acids in
the juxtamembrane region, which may be the result of alter-
native splicing. A Northern blot of 10-day-old chicken em-
bryo brain and body tissue was screened with a probe specific
for cek5+ and one that would recognise both cekS and
cek5+. Using the probe that recognises both cek5s a 4.4kb
transcript was detected in 10 day embryonic brain and body
tissues, with a 10 kb transcript also being detected in the
brain. The cek5 probe detected the 4.4kb transcript only,
and this was expressed exclusively in the CNS. cek5S
therefore appears to be a neuronal-specific variant of
cek5.
sek
Another eph family member, sek (segmentally expressed
kinase), seems to be involved in the development of the
mouse hindbrain. sek was isolated from an 8.5 day mouse
embryo cDNA library and the gene has been mapped to
mouse chromosome 1 and human chromosome 2 (Gilardi-
Hebenstreit et al., 1992). Murine sek mRNA is 7.0 kb in size
and was found to be most highly expressed in the adult
mouse brain. However it was also detectable in the heart and
lung, with a lower level of expression being seen in the
kidney (Table I). A detailed study of the expression of
mRNA in the developing mouse brain revealed sek is exp-
ressed initially in the forebrain and hindbrain but not in the
midbrain, with expression becoming more restricted within
the developing forebrain (Nieto et al., 1992). sek also appears
to be expressed in the developing neural tube of the spinal cord and sek may therefore have a role to play in the initial
steps of neuronal differentiation in the spinal cord of the
mouse. Later on in development sek may play a role in
neuronal maintenance as is suggested for cek5.
cek4/mek4/hek
Chicken cek4 (isolated at the same time as cek5) encodes a
7.5 kb mRNA which was detectable in brain, head structures
and body tissues of an 8 day chicken embryo (Sajjadi et al.,
1991). Expression of the 7.5 kb transcript was most pro-
nounced in adult brain and retina, but was detectable in all
other adult tissue except the liver (Sajadi & Pasquale, 1993).
cek4 was used to isolate the mouse homologue termed mek4
(mouse embryo kinase) (Saijadi et al., 1991), not to be con-
fused with MAP kinase/ERK kinase (MEK), which is res-
ponsible for phosphorylating the extracellular signal- regulated kinases (ERK) (Crews et al., 1992). A cDNA
coding for a soluble form of mek4 was isolated at the same
time as the usual membrane-spanning form. The soluble
form consists of the extracellular domain only and possesses
no transmembrane coding region. The mek4 gene that codes
for the full-length and secreted form of the receptor possesses
an internal exon which encodes a polyadenylation signal. Use
of this exon would result in the secreted form of mek4 being transcribed. This phenomenon has been noted for various
RTKs, including the EGF receptor, c-erbB-2 and some of the
FGF receptors. There is evidence to suggest that expression of truncated receptor tyrosine kinases are developmentally regulated (Vu et al., 1989), however the function of these
secreted extracellular domains has not been determined. One
suggestion is that they may help regulate the levels ofgrowth factors surrounding the cell or alternatively they could bind
to the full-length receptor and inhibit activation by prevent- ing productive dimerisation (Petch et al., 1990).
The mek4 mRNA is 6.0 kb in length and expression is
similar to elk in that the highest level is seen in the brain and
a lower level is detected in the testis, but the mRNA found
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here is only 3.4 kb in length and may represent a third form
of this receptor, which may again be the result of alternative
splicing (Table I). No mRNA of the soluble form of mek4
was detected, and it may be that this form is expressed in a
tissue-specific and/or a stage-specific manner. Further studies
are required to confirm this.
The human homologue of cek4/mek4 is termed hek. This
was cloned from a cDNA library prepared from mRNA
obtained from a human pre-B-cell line LK63/C20+ (a variant
of the parental cell line, LK63) (Wicks et al., 1992). A
monoclonal antibody, III.A4, which recognises the human
Hek protein, was made by immunising Balb/c mice with the
LK63 cell line. This was then used to perform biochemical
analysis on the Hek protein. Immunoprecipitation of labelled
Hek from LK63 cells showed the mature protein to have a
molecular mass of 135 kDa, and 95 kDa when deglycosy-
lated. When Hek was immunoprecipitated from LK63 cells
labelled in vivo with 32p, a weak band of 135 kDa was
detected, suggesting that Hek had been phosphorylated to a
low level. However, in attempts to find a specific ligand, no
increase in phosphorylation of Hek was observed when cells
were treated with a variety of cytokines (Boyd et al.,
1992).
Two approaches were taken to determine the distribution
of the Hek protein in normal and tumour tissue. The first
was using immunocytochemistry on frozen sections of solid
human biopsy tissues and the second was immunofluores-
cence followed by flow cytometry on single-cell suspensions
of haemopoietic cells and solid human tissues. The results
showed that normal tissue (spleen, lymph node, bone mar-
row, tonsil, breast and brain) and some acute lymphoblastic
leukaemia, breast, cervical, prostate, ovarian and renal car-
cinomas were negative for Hek protein expression, whereas
1/28 chronic lymphocytic leukaemias and 2/39 acute myeloid
leukaemias were positive. These data suggest that Hek may
play a role in some human haematopoietic cell tumours.
Northern blots of mRNA from LK63 and the T-cell line
JM probed with the hek cDNA revealed a band of
5.5-6.0 kb. When Southern blot analysis was performed on
DNA prepared from LK63 and LK63/C20+, which express
higher levels of hek than LK63 cells, no amplification or
rearrangement of the hek gene was detected. Further studies
should be undertaken to determine whether the hek gene is
overexpressed and/or amplified in human haematopoetic cell
tumours and/or solid human tumours.
hek2
The hek2 gene was isolated using PCR technology. Human
cDNAs from embryonic tissue were used as templates and
the primers were designed to specifically recognise eph-like
receptors. The predicted amino acid sequence on the hek2
gene is most similar to the partially sequenced eph-like recep-
tor, ceklO (Figure 1), and the gene has been located to the
distal end of human chromosome 3. Northern blot analysis
of human tissue, using the hek2 probe, recognised a tran-
script of 4.6 kb. Expression was highest in pancreas, lung,
placenta, brain and kidney, with lower expression being
noted in heart, skeletal muscle and liver (Table I). hek2
transcripts were also detected in tumour cell lines of
squamous and breast origin but not from epithelial cells of
the lung or HeLa cells. A hek2 transcript was detected in
A431 cells and lysate from these cells was used in an in vitro
kinase assay using polyclonal antibodies which were raised
against a synthetic peptide to the C-terminal end of the
predicted Hek2 protein sequence. The phosphorylated Hek2
protein was determined to be approximately 130 kDa
(Bohme et al., 1993).
Partially sequenced eph family members
Many partial cDNA sequences of putative receptors belong-
ing to the eph family have been reported. eek (eph-and
elk-related kinase) was isolated from a rat brain cDNA
library and was used to isolate human erk (elk-related kinase)
(Chan & Watt, 1991). This should not be confused with the
ERK proteins, which are extracellular signal-regulated
kinases which become phosphorylated by MEK (Crews et al.,
1992). eek mRNA was only detectable in the rat brain,
whereas erk mRNA was highest in lung and lower in rat
placenta, brain and kidney. Recently a longer clone of erk
was isolated from a human gastric cancer cDNA library and
found to differ from the original clone in one predicted
amino acid residue (Iwase et al., 1993). Northern blots of
RNA prepared from the stomach of embryonic and adult
rats plus mRNA from three cases of human gastric cancer
were probed with this longer erk clone. It was found that erk
was preferentially expressed in 16 day rat embryo stomach
and weakly, if at all, in the adult forestomach and glandular
stomach. erk expression was much higher in 3/3 human
gastric cancers examined when compared with normal gastric
tissue. erk may therefore play a role in human gastric
cancer.
In another study using PCR technology five partial
sequences coding for eph-like receptors, tyro1, 4, 5, 6 and 11,
were identified using rat cDNA as the template (Lai &
Lemke, 1991). When their predicted amino acid sequences
are compared with all other Eph-like receptors it is noted
that 100% identity exists between rat Tyrol and mouse
Sek/chicken Cek8 (see below). One hundred per cent identity
is also shared between Tyro4 and human Hek, Tyro5 and
human Erk and Tyro6 and human Hek2. Tyroll is most
closely related (93% identical) at the predicted amino acid
level to human Hek2. These partial clones may therefore
represent rat homologues of the given full-length Eph-like
receptors. The expression of the various tyro mRNAs in
adult and neonatal rat tissues was examined. tyrol and 4 are
preferentially expressed in the cells of the CNS and the level
is fairly constant from embryo day 12 to adulthood for tyrol,
whereas tyro4 expression drops sharply at birth. tyro5
mRNA is found exclusively in the neural tissue, and the level
of expression falls shortly after birth. tyro6 mRNA is found
in the brain, where expression is maximal at embryonic day
12, after which it gradually falls and by 10 days after birth is
fairly constant. tyroll has a different expression pattern and
is found predominantly in the heart and kidney, with a lower
level being detectable in neural tissue. Five partial length
eph-like receptor cDNAs were isolated from the 10 day
chicken embryo cDNA library, used to isolate cek4 and 5,
and a 13 day chicken embryo brain cDNA library (Sajadi &
Pasquale, 1993). These have been termed cek6, cek7, cek8,
cek9 and ceklO. cek6 is thought to be the avian homologue
of rat elk, while cek8 is considered to be the avian
homologue of rat tyrol and murine sek. ceklO is thought to
be the avian homologue of human hek2, whereas cek7 and
cek9 appear to be new eph-like receptors (see the
phylogenetic tree in Figure 1). cek7 mRNAs were found to
be mainly expressed in embryonic and adult brain. The
highest level of cek8 mRNA expression is found in the adult
chicken brain and retina. cek9 mRNA levels were highest in
the adult chicken thymus, and lower in the brain, retina,
kidney, lung and heart (Table I).
A variant form of ceklO, termed cekIO+, was isolated. This
variant possesses an insert of 15 amino acids in the jux-
tamembrane domain, similar to that seen with the cek5
variant, cekS+. This variation may be the result of alternative
splicing, but the significance of this is as yet unclear.
A partial eph-like receptor sequence was isolated using
PCR technology. mRNA from a human breast cancer cell
line was used as the template and the primers were
degenerate oligonucleotides to protein kinases. One out of 32
tyrosine kinase-coding PCR products was found to belong to
the eph family and was termed tk2 (Cance et al., 1993). At
the predicted amino acid level, 91% identity is shared
between Tk2 and human Eck. The level of tk2 expression
was beyond the limits of detection of a Northern blot of
RNA prepared from various epithelial cell lines. However,
tk2 expression could be detected in some of these cell linesTHE eph FAMILY OF GROWTH FACTOR RECEPTORS 421
when PCR technology was used, but when nine human
primary and metastatic breast cancers were examined using
this technique tk2 was undetectable.
Conclusions
Owing to modern molecular biology techniques the eph
family is rapidly expanding, and is presently the largest
known family of RTKs. However, at present only very
limited information as to their possible functions is available.
It appears that sek, cek5, elk, eek and possibly tyrol, 4, 5 and
6 may have roles to play in the development of the brain and
CNS, and in the maintenance of these tissues. As to the
functions of the remaining family members, further studies
must be undertaken before any conclusions can be made.
Although there is preliminary evidence to suggest that eph,
hek, erk and elk may be involved in some forms of human
cancers, larger studies are necessary to confirm this. Other
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family members should also be investigated for mutations,
gene amplification and/or overexpression in human car-
cinomas.
There is evidence to suggest that cek5, ceklO and mek4
may exist as alternatively spliced variants. The significance of
the resulting truncated receptor, in the case of mek4, or
receptors possessing inserts in the juxtamembrane region, as
is seen with cek5+ and cekl0O, is as yet unknown, however
this warrants further investigation. The other eph-like recep-
tors should also be examined for splice variants.
Once the ligands for the Eph-like receptors have been
identified, biochemical studies will be possible and the true
functions of this large family of 'putative' growth factor
receptors will begin to be unravelled.
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